We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
-7.79%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.41B
AUM Growth
-$143M
Cap. Flow
+$78.9M
Cap. Flow %
5.61%
Top 10 Hldgs %
48.2%
Holding
246
New
54
Increased
32
Reduced
53
Closed
52

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$38M
2
FOLD
Amicus Therapeutics
FOLD
+$22M
3
ACRS icon
Aclaris Therapeutics
ACRS
+$21.2M
4
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$18.7M
5
ANIP icon
ANI Pharmaceuticals
ANIP
+$15.6M

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$25.1M
2
DXCM icon
DexCom
DXCM
+$15.7M
3
AERI
Aerie Pharmaceuticals
AERI
+$13.5M
4
ASRT
Assertio
ASRT
+$13.4M
5
CRBP icon
Corbus Pharmaceuticals
CRBP
+$11.1M

Sector Composition

Rank Sector Weight
1 Healthcare 97.84%
2 Miscellaneous 1.6%
3 Consumer Staples 0.43%
4 Consumer Discretionary 0.07%
5 Industrials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMAG
101
DELISTED
AMAG Pharmaceuticals
AMAG
$679K 0.05%
19,524
– –
EXAS
102
PUT
DELISTED
Exact Sciences
EXAS
$670K 0.05%
+200,000
New +$3.23M
SYNH
103
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$665K 0.05%
12,636
– –
TARA icon
104
Protara Therapeutics
TARA
$222M
$635K 0.05%
8,353
+1,628
+24% +$515K
ENZ
105
DELISTED
Enzo Biochem, Inc.
ENZ
$582K 0.04%
83,893
+16,780
+25% +$107K
STLA icon
106
Stellantis
STLA
$14.8B
$565K 0.04%
62,248
– –
MGLN
107
DELISTED
Magellan Health Services, Inc.
MGLN
$565K 0.04%
7,508
-1,264
-14% -$80.9K
INCY icon
108
Incyte
INCY
$24.7B
$563K 0.04%
5,619
– –
SCYX icon
109
SCYNEXIS
SCYX
$43.7M
$546K 0.04%
2,140
– –
BIIB icon
110
Biogen
BIIB
$31.9B
$545K 0.04%
1,922
+1
+0.1% +$296
CCRN
111
DELISTED
Cross Country Healthcare
CCRN
$544K 0.04%
+34,819
New +$477K
HUM icon
112
CALL
Humana
HUM
$47.6B
$528K 0.04%
40,000
+39,600
+9,900% +$7.55M
ONSIZ
113
DELISTED
Oncobiologics, Inc. Series B Warrant
ONSIZ
$518K 0.04%
656,382
– –
ICLR icon
114
Icon
ICLR
$13.3B
$517K 0.04%
6,873
– –
UNH icon
115
UnitedHealth
UNH
$337B
$516K 0.04%
3,223
-8
-0.2% -$1.2K
TCON
116
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$490K 0.03%
+500
New +$571K
AMN icon
117
AMN Healthcare
AMN
$1.32B
$484K 0.03%
12,585
-860
-6% -$29.4K
AGTC
118
DELISTED
Applied Genetic Technologies Corporation
AGTC
$470K 0.03%
50,251
-375,797
-88% -$3.38M
LNTH icon
119
Lantheus
LNTH
$6.58B
$462K 0.03%
53,763
– –
ESRX
120
DELISTED
Express Scripts Holding Company
ESRX
$457K 0.03%
+6,639
New +$476K
HUM icon
121
Humana
HUM
$47.6B
$454K 0.03%
+2,227
New +$425K
SYRE icon
122
Spyre Therapeutics
SYRE
$8.02B
$451K 0.03%
4,143
– –
HRC
123
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$445K 0.03%
7,930
-1,633
-17% -$92.6K
MCK icon
124
McKesson
MCK
$105B
$432K 0.03%
3,078
+99
+3% +$14.6K
IMDZ
125
DELISTED
Immune Design Corp.
IMDZ
$428K 0.03%
77,725
– –
3 4
5
6 7

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Perceptive Advisors held 246 positions worth $1.41B, down 9.2% from $1.55B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Perceptive Advisors deployed $78.9M of net new capital in Q4 2016, opening 54 new positions and adding to 32 existing holdings. Its largest new stake was Lakefront Biotherapeutics American Depositary Shares: 304,531 shares worth $20.6M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 97% a quarter earlier, followed by Miscellaneous and Consumer Staples.

On the sell side, the largest reduction was Sarepta Therapeutics, an estimated $25.1M trimmed.

  • Perceptive Advisors's largest Q4 2016 buy was Lakefront Biotherapeutics American Depositary Shares: 304,531 shares worth $20.6M.
  • Perceptive Advisors added most to Neurocrine Biosciences in Q4 2016, an estimated $38M increase.
  • Perceptive Advisors's biggest Q4 2016 reduction was Sarepta Therapeutics, cutting an estimated $25.1M.
  • Perceptive Advisors fully exited DexCom in Q4 2016, selling an estimated $15.7M.
  • Perceptive Advisors's ten largest holdings make up 48% of its $1.41B portfolio in Q4 2016.
  • Perceptive Advisors opened 54 new positions and closed 52 in Q4 2016.
  • Perceptive Advisors's portfolio value fell 9.2% quarter-over-quarter to $1.41B.

Based on Perceptive Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.